RISK
IDENTIFIED

May is Skin Cancer Awareness Month—a time to focus on the importance of early detection, education, and personalized care. At Castle Biosciences, we are committed to helping individuals with skin cancer make informed decisions about their treatment through innovative diagnostic testing

Your tumor biology matters

Gene expression profile testing is a type of lab test that looks at the activity of certain genes in a tumor. Instead of focusing on how the tumor looks under a microscope, this test analyzes how the genes inside the tumor are working. The results can help predict how the cancer might behave—like whether it’s more likely to come back or spread—so you and your doctor can make more informed, personalized decisions about your care.

  • decisionDx-melanoma

    DecisionDx-Melanoma is a prognostic test for patients diagnosed with Stage I – III cutaneous melanoma. Our test looks at your tumor biology to predict the risk of your melanoma spreading or coming back.

    Learn more
  • Decisiondx-scc

    DecisionDx-SCC is a genomic test that looks at the tumor biology of your squamous cell carcinoma (SCC) of the skin to better understand the risk of your cancer spreading to other parts of your body. 

    Learn more

Hear stories from patients like you

  • Facing melanoma: Leah B's journey from PA to patient

      
    When Leah became a dermatology physician assistant, she never imagined that one day she would become a patient. In January 2022, just five days after her wedding, she received the call that changed her life.

  • Don Yeager, a cancer survivor and entrepreneur, shares his personal journey from diagnosis to peace of mind

       
    After discovering skin cancer, Don’s medical team used the     DecisionDx-SCC test by Castle Biosciences to assess his risk of recurrence. The results helped shape his treatment plan and ultimately led to incredible news—on that day, he was cancer-free.

Take the next step towards personalized care